Clinical Trial

Effect of Remote Ischemic Preconditioning on Early Neurological Deterioration in Acute Perforating Artery Infarction

Study acronym: RIC-END
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to conduct a prospective, randomized, double-blind, multicenter, parallel-controlled, group-sequential trialto scientifically evaluate the safety and efficacy of remote ischemic preconditioning (RIC) in preventing early neurological deterioration (END) in patients with acute perforating artery infarction (PAI).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-16; most recent amendment 2026-01-30.
Status change: Not Yet Recruiting → Recruiting 2025-11-19
Trial Details
NCT Number NCT07237542
Lead Sponsor Jinling Hospital, China
Conditions Ischemic Stroke, Remote Ischaemic Preconditioning
Enrollment 910 participants
Start Date 2025-12-11
Primary Completion 2027-11-20 (estimated)
Study Completion 2027-11-20 (estimated)
Updated on ClinicalTrials.gov 2026-02-03